Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...

SIOUX FALLS, SD / ACCESS Newswire / May 1, 2025 / Teen mental health has reached a crisis point in the United States. According to the CDC, nearly 1 in 3 high school girls reported seriously ...

Cash Burn of $4.0 million in Q1 remains in line with projected quarterly rangeCash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the ...

BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod (formerly called OK-101) to treat NCP, an ocular condition associated with chronic ...

Clinigen, the global specialist pharmaceutical services group, today announced the appointment of Nihad Hasagic as Senior Vice President for Clinigen Lifecycle Services (SVP CLS). Reporting to the ...

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), today announced that it has completed its first life cycle assessment (LCA) for its market-leading BK357 ...

Robust project management is essential in any manufacturing business, particularly where strict regulations and complex ...

Aspira Women's Health Submits the Third Milestone of ARPA-H $10 Million Award  AUSTIN, TX / ACCESS Newswire / May 1, 2025 / Aspira Women's Health Inc. ("Aspira") (OTC PINK:AWHL), a bio-analytical ...

Reports first quarter revenues of $0.1 billion, GAAP net loss of $(1.0) billion and GAAP EPS of $(2.52)Reiterates 2025 expected revenue range of $1.5 to $2.5 billion and 2025 year-end cash balance of ...

Acquisitions are On Track and Progressing From Signing to Closing; Guidance of $65M+ In Pro Forma Revenues Remains In PlaceTRNR Expects to Provide Positive Update on Sportstech Q1 2025 Performance in ...